Skip to main content

Table 2 Univariate analysis of the overall survival of two groups divided on the basis of the CA19-9 cutoff value in patients with PDAC treated by resection

From: Elevated serum CA19-9 level is a promising predictor for poor prognosis in patients with resectable pancreatic ductal adenocarcinoma: a pilot study

Cutoff value (U/mL)

Number (n = 120)

Median OS (months)

Log rankx2

P value

<37

18

21.6

6.647

0.010

≥37

102

14.2

  

<200

52

19.2

2.105

0.147

≥200

68

13.9

  

<287.61

60

19.2

3.923

0.048

≥287.61

60

12.7

  

<338.45

68

24.9

6.868

0.009

≥338.45

52

11.9

  

<617.31

79

19.2

4.696

0.030

≥617.31

41

12.0

  

<1,000

93

15.9

0.827

0.363

≥1,000

27

12.0

 Â